NeuroPace reported earnings of -$ 0.10 per NPCE share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.11 |
| Earnings Per Share (Surprise) | -$ 0.10 (+$ 0.00875) |
| Last Year's EPS | -$ 0.16 |
| EPS YoY Change |
Out of the last 27 earnings reporting periods, NeuroPace beat analysts’ expectations 15 times and fell short of expectations 7 time(s). NeuroPace reported earnings per share of -$ 0.10 in the last report surpassing an estimated EPS of -$ 0.11 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.11 | -$ 0.10 | -$ 0.11 | |
| Aug 11, 2026 | -$ 0.22 | -$ 0.18 | -$ 0.26 | |
| May 12, 2026 | -$ 0.19 | -$ 0.20 | -$ 0.21 | |
| Mar 3, 2026 | -$ 0.14 | -$ 0.08 | -$ 0.18 | |
| Nov 4, 2025 | -$ 0.20 | -$ 0.11 | -$ 0.19 | |
| Aug 12, 2025 | -$ 0.24 | -$ 0.26 | -$ 0.26 | |
| May 13, 2025 | -$ 0.26 | -$ 0.21 | -$ 0.32 | |
| Mar 4, 2025 | -$ 0.25 | -$ 0.18 | -$ 0.23 | |
| Nov 12, 2024 | -$ 0.26 | -$ 0.19 | -$ 0.28 | |
| Aug 13, 2024 | -$ 0.29 | -$ 0.26 | -$ 0.36 | |
| May 8, 2024 | -$ 0.32 | -$ 0.32 | -$ 0.41 | |
| Mar 5, 2024 | -$ 0.33 | -$ 0.23 | -$ 0.45 | |
| Nov 6, 2023 | -$ 0.39 | -$ 0.28 | -$ 0.48 | |
| Aug 8, 2023 | -$ 0.47 | -$ 0.36 | -$ 0.52 | |
| May 4, 2023 | -$ 0.46 | -$ 0.41 | -$ 0.47 | |
| Mar 2, 2023 | -$ 0.49 | -$ 0.45 | -$ 0.44 | |
| Nov 8, 2022 | -$ 0.52 | -$ 0.48 | -$ 0.34 | |
| Aug 11, 2022 | -$ 0.44 | -$ 0.52 | -$ 0.36 | |
| May 12, 2022 | -$ 0.46 | -$ 0.47 | -$ 21.21 | |
| Mar 10, 2022 | -$ 0.33 | -$ 0.44 | -$ 0.37 |
NeuroPace’s stock was trading at $ 12.52 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, NPCE’s price decreased to $ 7.56 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.10 | $ 12.52 | $ 7.56 | |
| Aug 11, 2026 | -$ 0.18 | $ 14.88 | $ 14.56 | |
| May 12, 2026 | -$ 0.20 | $ 15.67 | $ 15.81 | |
| Mar 3, 2026 | -$ 0.08 | $ 14.15 | $ 13.95 | |
| Nov 4, 2025 | -$ 0.11 | $ 9.40 | $ 12.98 | |
| Aug 12, 2025 | -$ 0.26 | $ 8.89 | $ 9.32 | |
| May 13, 2025 | -$ 0.21 | $ 13.37 | $ 15.60 | |
| Mar 4, 2025 | -$ 0.18 | $ 11.81 | $ 11.63 | |
| Nov 12, 2024 | -$ 0.19 | $ 7.28 | $ 9.15 | |
| Aug 13, 2024 | -$ 0.26 | $ 6.90 | $ 6.77 | |
| May 8, 2024 | -$ 0.32 | $ 13.30 | $ 7.97 | |
| Mar 5, 2024 | -$ 0.23 | $ 13.87 | $ 13.98 | |
| Nov 6, 2023 | -$ 0.28 | $ 7.17 | $ 7.07 | |
| Aug 8, 2023 | -$ 0.36 | $ 4.10 | $ 4.50 | |
| May 4, 2023 | -$ 0.41 | $ 4.86 | $ 4.95 | |
| Mar 2, 2023 | -$ 0.45 | $ 4.73 | $ 4.10 | |
| Nov 8, 2022 | -$ 0.48 | $ 2.33 | $ 2.10 | |
| Aug 11, 2022 | -$ 0.52 | $ 5.68 | $ 5.48 | |
| May 12, 2022 | -$ 0.47 | $ 6.08 | $ 6.15 | |
| Mar 10, 2022 | -$ 0.44 | $ 8.15 | $ 8.08 |
NeuroPace released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
NeuroPace beat analysts’ expectations during the last earnings period by
